Find uplifting stories about heroes, innovations, and solutions
118 results for "clinical trials"
A breakthrough treatment for ulcerative colitis brought 40% of patients into remission after just 12 weeks, offering fresh hope for millions living with inflammatory bowel disease. Spyre Therapeutics' experimental drug succeeded in its first major trial, setting up competition with pharmaceutical giants to deliver better digestive disease treatments.
-growing-in-single-files-along-collagen-fibres-(red)_renee-flaherty.jpg%3Fsfvrsn%3Db3bf3bc8_1)
A drug already in trials for blood cancer could transform treatment for lobular breast cancer, a difficult-to-detect form affecting 15% of breast cancer patients. Scientists found the drug slowed tumor growth and spread in mice with minimal side effects.
After years of success in mice, researchers are launching the first human trial of a cellular therapy that could turn back the clock on aging tissues and organs. The groundbreaking test could reshape how we think about getting older.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
A promising therapy for fragile X syndrome, a leading genetic cause of autism, is moving to human trials after securing funding from strategic partners. The treatment could also help patients with other rare brain disorders.
A breakthrough medication called Lunsekimig showed promising results in global trials, offering hope that asthma patients might one day reduce or eliminate their dependence on inhalers. The drug targets the root cause of airway inflammation rather than just treating symptoms.
A mother who raised $1.3 million to fund a controversial treatment for her son's fatal muscle disease just saw clinical trial results that stunned experts. The experimental drug uses a counterintuitive approach: fixing broken genes by breaking them a little more.
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
A groundbreaking treatment that makes old cells young again is moving to human trials this year, starting with restoring vision in glaucoma patients. After years of successful tests in mice, this breakthrough could one day rejuvenate aging organs throughout the body.
Greek scientists created an AI tool that spots dangerous heart problems using common ultrasound equipment, achieving over 90% accuracy in clinical trials. The breakthrough could help millions get life-saving diagnoses without expensive MRI scans.
A Virginia heart center just became the first in the state to implant a foam device that could protect people with irregular heartbeats from strokes. The innovative treatment offers hope for patients who can't take blood thinners.
Scientists are testing breakthrough treatments that could eliminate type 1 diabetes symptoms within the next few years. Late-stage trials of beta cell replacement therapy are showing real promise for millions living with the disease.
Single-session therapy is helping people tackle mental health challenges in just 60 minutes, offering an accessible alternative when traditional therapy feels out of reach. Research across 415 clinical trials shows it works for depression, anxiety, and more.
A promising ALS treatment has enrolled its first patient in a major clinical trial that could slow disease progression. The drug showed encouraging results in early-stage patients during previous testing.
A groundbreaking ALS treatment has enrolled its first patient in a major clinical trial that could help slow disease progression in early-stage patients. The study follows encouraging results showing the drug helped preserve speech and breathing function in rapid-decline patients.
A 70-year-old Houston woman with advanced cervical cancer is now cancer-free after trying an experimental immunotherapy treatment. Her remarkable recovery offers new hope for patients facing similar diagnoses.
University of South Florida researchers are running clinical trials using psilocybin to help people with serious mental health conditions. The studies could open new treatment paths for patients who haven't found relief through traditional therapies.
A once-daily pill called zasocitinib cleared severe psoriasis in 70% of patients within 16 weeks, matching results previously only seen with injections. The breakthrough could transform treatment for millions who've had to choose between convenience and effectiveness.
A biotechnology company just manufactured the first batch of a groundbreaking therapy that could help millions of people suffering from diabetic foot ulcers. The treatment uses a novel approach that's never been produced at this scale before.
A new treatment from Biogen is showing encouraging results for people living with lupus, particularly helping clear painful skin symptoms. The mid-stage clinical trial marks a hopeful step forward for the millions worldwide affected by this autoimmune disease.
Showing 20 of 118